Disc Medicine Financial Ratios
NASDAQ: IRONHealth CareBiotechnology: Pharmaceutical PreparationsUSD
62.06+1.29 (+2.12%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Disc Medicine ratio analysis
Return on equity reached -28.7%, meaning Disc Medicine generated -0.29 dollars of profit for every dollar of shareholders' equity. Debt-to-equity stood at 0.04 versus 0.06 the year before, and the current ratio was 21.94. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Disc Medicine financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Price / book | 3.77 | 3.97 | 3.73 | 0.12 | — | — |
| Return on equity (ROE) | -28.7% | -24.7% | -22.1% | -26.5% | — | — |
| Return on assets (ROA) | -26.3% | -22.0% | -20.8% | -23.4% | -38.9% | -490.9% |
| Debt / equity | 0.04 | 0.06 | 0.00 | — | — | — |
| Current ratio | 21.94 | 21.17 | 17.06 | 8.79 | 6.74 | 0.20 |